- Home
- ALDX vs MHN Comparison
ALDX vs MHN Comparison
Compare ALDX & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MHN
- Stock Information
- Founded
- ALDX 2004
- MHN 1997
- Country
- ALDX United States
- MHN United States
- Employees
- ALDX N/A
- MHN N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MHN Investment Bankers/Brokers/Service
- Sector
- ALDX Health Care
- MHN Finance
- Exchange
- ALDX Nasdaq
- MHN Nasdaq
- Market Cap
- ALDX 319.4M
- MHN 334.2M
- IPO Year
- ALDX 2014
- MHN N/A
- Fundamental
- Price
- ALDX $4.85
- MHN $10.68
- Analyst Decision
- ALDX Strong Buy
- MHN
- Analyst Count
- ALDX 2
- MHN 0
- Target Price
- ALDX $10.00
- MHN N/A
- AVG Volume (30 Days)
- ALDX 571.6K
- MHN 59.2K
- Earning Date
- ALDX 11-07-2024
- MHN 01-01-0001
- Dividend Yield
- ALDX N/A
- MHN 4.17%
- EPS Growth
- ALDX N/A
- MHN N/A
- EPS
- ALDX N/A
- MHN N/A
- Revenue
- ALDX N/A
- MHN N/A
- Revenue This Year
- ALDX N/A
- MHN N/A
- Revenue Next Year
- ALDX $25.36
- MHN N/A
- P/E Ratio
- ALDX N/A
- MHN N/A
- Revenue Growth
- ALDX N/A
- MHN N/A
- 52 Week Low
- ALDX $2.43
- MHN $8.69
- 52 Week High
- ALDX $6.55
- MHN $10.81
- Technical
- Relative Strength Index (RSI)
- ALDX 45.59
- MHN 45.99
- Support Level
- ALDX $4.66
- MHN $10.69
- Resistance Level
- ALDX $5.01
- MHN $10.79
- Average True Range (ATR)
- ALDX 0.40
- MHN 0.08
- MACD
- ALDX -0.01
- MHN 0.00
- Stochastic Oscillator
- ALDX 46.06
- MHN 27.43
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About MHN Blackrock MuniHoldings New York Quality Fund Inc.
BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.